Literature DB >> 26369516

Ocular motor signatures of cognitive dysfunction in multiple sclerosis.

Joanne Fielding1,2, Meaghan Clough1, Shin Beh3, Lynette Millist2, Derek Sears3, Ashley N Frohman3, Nathaniel Lizak4, Jayne Lim2, Scott Kolbe5, Robert L Rennaker6, Teresa C Frohman3, Owen B White2, Elliot M Frohman3,6.   

Abstract

The anatomical and functional overlap between ocular motor command circuitry and the higher-order networks that form the scaffolding for cognition makes for a compelling hypothesis that measures of ocular motility could provide a means to sensitively interrogate cognitive dysfunction in people with multiple sclerosis (MS). Such an approach may ultimately provide objective and reproducible measures of cognitive dysfunction that offer an innovative capability to refine diagnosis, improve prognostication, and more accurately codify disease burden. A further dividend may be the validation and application of biomarkers that can be used in studies aimed at identifying and monitoring preventative, protective and even restorative properties of novel neurotherapeutics in MS. This Review discusses the utility of ocular motor measures in patients with MS to characterize disruption to wide-ranging networks that support cognitive function.

Entities:  

Mesh:

Year:  2015        PMID: 26369516     DOI: 10.1038/nrneurol.2015.174

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  83 in total

1.  The effect of cognitive load on saccadic eye movements.

Authors:  E Stuyven; K Van der Goten; A Vandierendonck; K Claeys; L Crevits
Journal:  Acta Psychol (Amst)       Date:  2000-03

Review 2.  Role of the lateral prefrontal cortex in executive behavioral control.

Authors:  Jun Tanji; Eiji Hoshi
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

3.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

4.  Differential cortical activation during voluntary and reflexive saccades in man.

Authors:  Dominic J Mort; Richard J Perry; Sabira K Mannan; Timothy L Hodgson; Elaine Anderson; Rebecca Quest; Donald McRobbie; Alan McBride; Masud Husain; Christopher Kennard
Journal:  Neuroimage       Date:  2003-02       Impact factor: 6.556

5.  Cognitive impairment in different MS subtypes and clinically isolated syndromes.

Authors:  Constantin Potagas; Erasmia Giogkaraki; Georgios Koutsis; Dimitrios Mandellos; Erifylli Tsirempolou; Constantin Sfagos; Demetris Vassilopoulos
Journal:  J Neurol Sci       Date:  2007-11-13       Impact factor: 3.181

Review 6.  Cognitive changes in multiple sclerosis.

Authors:  Maria Pia Amato; Valentina Zipoli; Emilio Portaccio
Journal:  Expert Rev Neurother       Date:  2008-10       Impact factor: 4.618

7.  Attentional blink in adults with attention-deficit hyperactivity disorder. Influence of eye movements.

Authors:  I T Armstrong; D P Munoz
Journal:  Exp Brain Res       Date:  2003-07-08       Impact factor: 1.972

8.  Dysarthria predicts poorer performance on cognitive tasks requiring a speeded oral response in an MS population.

Authors:  Megan M Smith; Peter A Arnett
Journal:  J Clin Exp Neuropsychol       Date:  2007-11       Impact factor: 2.475

9.  Impaired inhibitory control is associated with higher-order repetitive behaviors in autism spectrum disorders.

Authors:  M W Mosconi; M Kay; A-M D'Cruz; A Seidenfeld; S Guter; L D Stanford; J A Sweeney
Journal:  Psychol Med       Date:  2009-01-21       Impact factor: 7.723

Review 10.  Cognitive impairment in multiple sclerosis.

Authors:  Alexander Winkelmann; Claudia Engel; Annett Apel; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

View more
  4 in total

1.  Impairment of Smooth Pursuit as a Marker of Early Multiple Sclerosis.

Authors:  Nathaniel Lizak; Meaghan Clough; Lynette Millist; Tomas Kalincik; Owen B White; Joanne Fielding
Journal:  Front Neurol       Date:  2016-11-21       Impact factor: 4.003

Review 2.  Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment.

Authors:  Alessandro Serra; Clara G Chisari; Manuela Matta
Journal:  Front Neurol       Date:  2018-02-05       Impact factor: 4.003

3.  Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial.

Authors:  Kawita M S Kanhai; Jenny A Nij Bijvank; Yorick L Wagenaar; Erica S Klaassen; KyoungSoo Lim; Sandrin C Bergheanu; Axel Petzold; Ajay Verma; Jacob Hesterman; Mike P Wattjes; Bernard M J Uitdehaag; Laurentius J van Rijn; Geert Jan Groeneveld
Journal:  CNS Neurosci Ther       Date:  2019-02-12       Impact factor: 5.243

4.  A standardized protocol for quantification of saccadic eye movements: DEMoNS.

Authors:  J A Nij Bijvank; A Petzold; L J Balk; H S Tan; B M J Uitdehaag; M Theodorou; L J van Rijn
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.